Every 10-Q that DNA X (SONM) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow SONM and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full SONM filings page.
DNA X, Inc. (symbol SONM) reported a sharp strategic shift in the quarter ended June 30, 2026, completing the sale of its legacy rugged phone and hotspot business on January 23, 2026 and focusing on an AI‑driven crypto trading platform. The asset sale generated a $15.3 million pre‑tax gain and contributed to consolidated net income of $5.1 million for the first six months of 2026, compared with a $7.0 million loss a year earlier. Discontinued operations produced $10.3 million income for the six‑month period, while continuing operations recorded a $5.2 million loss with no revenues.
Balance sheet risk has been reduced but not eliminated. Total assets fell to $4.5 million from $43.9 million at December 31, 2025 after removing the sold business, while total liabilities declined to $5.7 million from $50.6 million. Stockholders’ deficit improved from $(8.0) million to $(1.2) million. Cash and cash equivalents were $0.9 million, with $5.5 million net cash used in operating activities in the first half. A related‑party convertible note of $3.1 million was outstanding at quarter‑end, with an associated $0.8 million derivative liability. After June 30, DNA X received $5.0 million of new cash from preferred stock sales to DNA Holdings and exchanged the note into preferred equity, which the company states is expected to fund completion of trading‑platform enhancements and obligations for the year following this report’s filing.
DNA X, Inc. (formerly Sonim Technologies) has completed a major strategic shift and now focuses on its DNA X AI and crypto trading platform after selling its legacy phone and hotspot business. The January 23, 2026 asset sale generated a pre-tax gain of $15,563 thousand and net income from discontinued operations of $10,268 thousand for the quarter, driving total net income to $6,340 thousand despite no revenue from continuing operations and a continuing-operations net loss of $3,928 thousand.
Total assets dropped to $4,838 thousand at March 31, 2026 from $43,898 thousand after removing the disposed business, while stockholders’ deficit narrowed to $983 thousand. Cash and cash equivalents were $1,195 thousand, and the company carries a related-party convertible note with a principal of $1,200 thousand plus a derivative liability of $398 thousand tied to its conversion features.
On May 20, 2026, DNA X issued a new related-party convertible promissory note with a principal balance of $3,053 thousand, receiving $1,800 thousand in cash and cancelling the prior note and accrued interest. Management states these proceeds are expected to fund operation of the AI and crypto platform through December 31, 2026, but also discloses substantial doubt about the company’s ability to continue as a going concern if the note is not converted or additional financing is not obtained.
Sonim Technologies (SONM) filed its Q3 2025 10‑Q, reporting total net revenues of $16.214 million and a net loss of $4.753 million. For the nine months, revenues were $44.125 million with a net loss of $11.770 million. Gross profit declined year over year in the quarter as costs rose.
Liquidity is tight: cash and equivalents were $2.137 million at September 30, 2025, with $21.522 million used in operating cash flow year to date and a stockholders’ deficit of $0.701 million. The company disclosed substantial doubt about its ability to continue as a going concern.
Sonim entered an asset purchase agreement to sell substantially all assets of its enterprise 5G solutions business for $15,000 cash, plus up to $5,000 earn‑out, subject to closing conditions; once closed, there will be no more revenue from the existing business. To fund operations, Sonim completed a July public offering of 411,111 shares at $13.50 (net proceeds ≈ $4.8 million), sold 193,405 shares via ATM (net $8.229 million), and entered a ChEF committed equity facility. Debt outstanding includes promissory notes with $5.680 million principal. A 1‑for‑18 reverse split became effective on October 27, 2025; 1,028,693 shares were outstanding on October 28, 2025.
Sonim Technologies, Inc. reported consolidated total assets of $36,078 and cash and cash equivalents of $2,006 at June 30, 2025. Total net revenues were $11,190 for the three months and $27,911 for the six months ended June 30, 2025, with gross profit of $845 for the quarter. The company recorded a net loss of $7,475 for the quarter and $7,017 for the six months, and used $14,488 of cash in operating activities during the six months. Stockholders' equity remained in a deficit of $1,334 and accumulated deficit totaled $290,625.
The company entered a material Asset Purchase Agreement dated July 17, 2025 to sell substantially all assets of its enterprise 5G solutions business for $15,000 in cash plus up to $5,000 of earn-out tied to Net Revenue above $70,000 for the 12-month period beginning July 1, 2025. Sonim also completed a July 2, 2025 public offering that raised net proceeds of approximately $4,800 and sold a promissory note for approximately $2,320, and obtained access to additional receivables financing (up to 0,000). Management states it believes these proceeds, together with cash at June 30, 2025, are sufficient to meet obligations for the next twelve months following the filing date.